TSS
PALI icon

Two Sigma Securities’s Palisade Bio PALI Stock Holding History

Two Sigma Securities’s Portfolio PALI Stock Details PALI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$57.4K Buy
+27,450
New +$54K ﹤0.01% 1377
2025
Q4 		– Sell
-29,406
Closed -$25.3K – 1875
2025
Q3 		$25.3K Buy
29,406
+13,437
+84% +$10.5K ﹤0.01% 1093
2025
Q2 		$10.9K Buy
15,969
+1,816
+13% +$1.3K ﹤0.01% 1292
2025
Q1 		$9.63K Buy
+14,153
New +$16.7K ﹤0.01% 1241
2024
Q2 		– Sell
-1,881
Closed -$11.3K – 3476
2024
Q1 		$11.3K Buy
1,881
+571
+44% +$3.98K ﹤0.01% 2750
2023
Q4 		$11.6K Buy
+1,310
New +$11.5K ﹤0.01% 2803
2023
Q1 		– Sell
-1,313
Closed -$102K – 3098
2022
Q4 		$102K Buy
1,313
+1,204
+1,105% +$69.8K ﹤0.01% 2061
2022
Q3 		$8K Buy
109
+68
+166% +$14.4K ﹤0.01% 2431
2022
Q2 		$12K Sell
41
-5
-11% -$2.41K ﹤0.01% 2028
2022
Q1 		$36K Buy
46
+27
+142% +$21.8K ﹤0.01% 1912
2021
Q4 		$19K Buy
+19
New +$33.2K ﹤0.01% 1410
2017
Q4 		– Hold
0
– -$40K – 1934
2017
Q3 		– Hold
0
– – – 763
2015
Q2 		– Hold
0
– -$26K – 240
2015
Q1 		– Hold
0
– – – 169

Other funds holding PALI

SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
BGI
B Group Inc Dallas, Texas $213M AUM 96.05% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Two Sigma Securities's PALI Position: Q2 2026 in Review

Two Sigma Securities opened a new position in Palisade Bio (PALI) in Q2 2026: 27,450 shares worth $57.4K. The stake represents ﹤0.01% of the portfolio and ranks #1377 among its holdings. This is a return to the name: Two Sigma Securities previously reported a position in PALI as recently as Q3 2025.

Two Sigma Securities first reported a position in PALI in Q4 2021 and has held it in 11 quarters since. The position peaked at $102K in Q4 2022. 124 funds tracked by Wall St. Rank hold PALI as of Q2 2026.

  • Two Sigma Securities held 27,450 shares of Palisade Bio worth $57.4K as of Q2 2026.
  • Palisade Bio was a new Two Sigma Securities position in Q2 2026.
  • Palisade Bio made up ﹤0.01% of Two Sigma Securities's portfolio in Q2 2026, its #1377 holding.
  • Two Sigma Securities first reported a position in Palisade Bio in Q4 2021 and has held it in 11 quarters since.
  • Two Sigma Securities's Palisade Bio position peaked at $102K in Q4 2022.
  • 124 funds tracked by Wall St. Rank held Palisade Bio as of Q2 2026.

Based on Two Sigma Securities's 13F filing for Q2 2026, filed 14 Aug 2026.